Literature DB >> 316334

Haemodynamic effects of disopyramide in patients after open-heart surgery.

N Naqvi, D S Thompson, W E Morgan, B T Williams, D J Coltart.   

Abstract

Disopyramide phosphate was administered intravenously in a dose of 1.2 mg/kg body weight over one minute to nine patients after open-heart surgery and coronary artery bypass grafting. The haemodynamic changes were studied during and for 30 minutes after drug administration. Heart rate was unchanged throughout the study. During infusion the only significant changes were an increase in systemic blood pressure and systolic impedance signifying a direct increase in peripheral arterial resistance. Systemic blood pressure remained significantly higher for 10 minutes and systolic impedance for 30 minutes. Immediately after infusion max. dPower/dT, a measure of ventricular contractility, was significantly depressed for 15 minutes. Both cardiac output and aortic flow were significantly depressed for 30 minutes. DPTI/TTI, an estimate of subendocardial supply/demand ratio, showed an insignificant increase throughout the study. This study shows that intravenous disopyramide starts acting within 45 seconds of the start of infusion, directly increases peripheral arterial resistance, has a breif negative inotropic action, and does not reduce subendocardial blood flow.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 316334      PMCID: PMC482205          DOI: 10.1136/hrt.42.5.587

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


  30 in total

1.  Acute termination of cardiac arrhythmias with intravenous disopyramide.

Authors:  H F Mizgala; P R Huvelle
Journal:  J Int Med Res       Date:  1976       Impact factor: 1.671

2.  A monitor for the continuous assessment of left ventricular performance after open-heart operations.

Authors:  A E Farnsworth; T A Angerpointner; G J Lewis; P R Bourne; B T Williams
Journal:  Ann Thorac Surg       Date:  1977-02       Impact factor: 4.330

3.  Pharmacology of a new antiarrhythmic agent, gamma-diisopropyl-amino-alpha-phenyl-alpha-(2-pyridyl)-butyramide (SC-7031).

Authors:  C M MOKLER; C G VAN ARMAN
Journal:  J Pharmacol Exp Ther       Date:  1962-04       Impact factor: 4.030

4.  Failure of general anesthesia to potentiate propranolol activity.

Authors:  S Slogoff; A S Keats; C W Hibbs; C H Edmonds; D A Bragg
Journal:  Anesthesiology       Date:  1977-12       Impact factor: 7.892

5.  Impotence in patient on disopyramide.

Authors:  D J McHaffie; A Guz; A Johnston
Journal:  Lancet       Date:  1977-04-16       Impact factor: 79.321

6.  Disopyramide in renal impairment.

Authors:  B Whiting; H L Elliott
Journal:  Lancet       Date:  1977 Dec 24-31       Impact factor: 79.321

7.  Closed-angle glaucoma in patient on disopyramide.

Authors:  G E Trope; V M Hind
Journal:  Lancet       Date:  1978-02-11       Impact factor: 79.321

Review 8.  The myocardial supply:demand ratio--a critical review.

Authors:  J I Hoffman; G D Buckberg
Journal:  Am J Cardiol       Date:  1978-02       Impact factor: 2.778

9.  Use of electromagnetic flow probes to assess myocardial performance in man.

Authors:  G J Lewis; P A Poole-Wilson; T Angerpointer; D J Coltart; B T Williams
Journal:  Eur J Cardiol       Date:  1978-06

10.  The antiarrhythmic efficacy of intravenous therapy with disopyramide phosphate.

Authors:  D A Deano; D Wu; R K Mautner; R H Sherman; A I Ehsani; K M Rosen
Journal:  Chest       Date:  1977-05       Impact factor: 9.410

View more
  5 in total

1.  An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: application to the administration of disopyramide.

Authors:  K Niki; M Sugawara; S Tanino; K Iwade; S Hosoda; H Kasanuki
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

Review 2.  New antiarrhythmic drugs: their place in therapy.

Authors:  D L Keefe; R E Kates; D C Harrison
Journal:  Drugs       Date:  1981-11       Impact factor: 9.546

Review 3.  Disopyramide. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiac arrhythmias.

Authors:  R N Brogden; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

4.  Effect of disopyramide on isolated aortic ring of the rat.

Authors:  R S de Moura; J S Lima
Journal:  Br J Pharmacol       Date:  1983-03       Impact factor: 8.739

5.  Negative inotropic effects of disopyramide on guinea-pig papillary muscles.

Authors:  N Kondo; M Mizukami; S Shibata
Journal:  Br J Pharmacol       Date:  1990-12       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.